Anti-RNP antibody in a child with undifferentiated carcinoma and no evidence of mixed connective tissue disease

British Journal of Rheumatology

Volumn 36, Issue 2, 1997, Pages 289-291

  Foster, H E ^a   Malleson, P N ^a   Petty, R E ^b   Cabral, D A ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anti RNP antibody; Antinuclear antibody; Autoantibodies; Childhood; Malignancy

Indexed keywords

ANTINUCLEAR ANTIBODY; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; RIBONUCLEOPROTEIN ANTIBODY;

ARTICLE; CASE REPORT; DIAGNOSTIC ERROR; FEMALE; HUMAN; METASTASIS; MIXED CONNECTIVE TISSUE DISEASE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; UNDIFFERENTIATED CARCINOMA;

EID: 0030860704     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.2.289     Document Type: Article

References (16)

1. Hainsworth JD, Johnson DH, Greco FA. Cis platinum based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: Results of a 12 year experience. J Clin Oncol 1992;10:912-22.
2. Harms D, Schmidt D. Rare tumours in childhood: Pathological aspects. Experience of the Kiel Paediatric tumour registry. Med Paediatr Oncol 1993;21:239-48.
3. Cassidy JT, Petty RE. Textbook of pediatric rheumatology, 3rd edn. New York: WB Saunders Co., 1995:451-5.
4. Sela O, Shoenfeld Y. Cancer in autoimmune diseases. Semin Arthritis Rheum 1988;18:77-87.
5. McCarty GA. Autoimmunity and malignancy. Med Clin North Am 1985;69:599-615.
6. Nelson DS. Autoantibodies in cancer patients. Pathology 1977;9:155-60.
7. Swissa M, Amital-Teplizki H, Haim N, Cohen Y, Shoenfeld Y. Autoantibodies in neoplasia. An unresolved enigma. Cancer 1990;65:2554-8.
8. Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity 1988;1:141-9.
9. Cabral DA, Petty RE, Fung M, Malleson PN. Persistent antinuclear antibodies in children without identifiable inflammatory or autoimmune disease. Pediatrics 1992;89:441-4.
10. Deane PM, Liard G, Siegal DM, Baum J. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 1995;95:892-5.
11. Niwa W, Sakani T, Tadashi K, Shichijo S, Widerhold MD, Yokoyama MM. Transient autoantibodies with elevated complement levels in common viral diseases. Clin Lab Immunol 1984;13:183-8.
12. Chudwin DS, Amman AJ, Cowan MJ, Wara DW. Significance of a positive antinuclear antibody test in a pediatric population. Arch Dis Child 1983;137:1103-6.
13. Arroyave CM, Giambrone MJ, Rich KC, Walaszek M. The frequency of antinuclear antibody (ANA) in children by use of mouse kidney (MK) and human epithelial cells (HEp-2) as substrates. J Allergy Clin Immunol 1988;82:741-4.
14. Goel KM, Shanks RA, Whaley K, Mason M, MacSween RNM. Autoantibodies in childhood connective diseases and in normal children. Arch Dis Child 1975;50:419-23.
15. Fairley CH. Autoantibodies in malignant disease. Br J Haematol 1972;23:31.
16. Wasserman J, Glash Blomeren H. Autoantibodies in patients with carcinoma of the breast: Correlation with prognosis. Clin Exp Immunol 1975;19:417-23.